Alopexx Enterprises Works With Scientists And Entrepreneurs To Build Successful New Companies We Invest In Novel Health Care Technologies At All Stages Of Development And Can Serve As A Lead Investor Or Collaborate With A Group Of Investors To Advance Important Science We Also Have The Capabilities To Provide Management And Development Expertise Where Needed To Dateour Initial Investments Have Ranged From $1 20M The Alopexx Team Consists Of Experts Who Have Deep Industry Knowledge And Technical Expertise In All Areas Of Drug Development Includingpharmacologycmctoxicologymedical And Clinical Operationsquality And Regulatory Affairswe Form Collaborations With Academic Institutionsbiotech And Pharmaceutical Companies To Advance Our Portfolio Companies To Deliver Breakthrough Therapies To Patients In Need Our Business Model Is To Invest And Develop To An Important Inflection Point And Then Partner The Asset For Further Development And Or Commercialization Portfolio Companies Include Alopexx Pharmaceuticals Alopexx Oncology Alopexx Vaccine Valerion Therapeutics Janus Biotherapeutics Cognoptix
